Sermorelin acetate
What it is
Sermorelin is GHRH(1-29), the shortest fragment of growth-hormone-releasing hormone that retains full activity at the GHRH receptor. It has been used clinically as a diagnostic agent and is a reference compound in pituitary research.
Where it has been studied
- GHRH receptor pharmacology
- Growth hormone release and pulsatility
- Sleep and neuroendocrine studies
Selected literature
- Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocityKirk JM et al. · Clin Endocrinol (Oxf), 1994 · PMID 7955460
- Continuous subcutaneous GHRH(1-29)NH2 promotes growth over 1 year in short, slowly growing childrenBrain CE et al. · Clin Endocrinol (Oxf), 1990 · PMID 2140733
- The GH response to low-dose bolus growth hormone-releasing hormone (GHRH(1-29)NH2) is attenuated in patients with longstanding post-irradiation GH insufficiencyAchermann JC et al. · Eur J Endocrinol, 2000 · PMID 10754477
PubMed records selected for relevance to the compound. They describe published research, not outcomes or uses.
